Sectors & Industries Consumer DefensivePharmaceutical Retailers
Best Pharmaceutical Retailer Stocks to Buy Now (2025)
Top pharmaceutical retailer stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best pharmaceutical retailer stocks to buy now. Learn More.

Industry: Pharmaceutical Retailers

Overview Zen Rating Price Value Growth Financials Momentum Sentiment Forecast Dividends

Pharmaceutical Retailers is Zen Rated D and is the 95th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	Dividend Yield	Payout Ratio	Last Dividend	Annual Dividend	Dividend Percentile	Dividend Dropped Count (L10Y)
YI	111 INC	$87.07M	N/A	N/A	N/A	N/A	N/A	N/A
HITI	HIGH TIDE INC	$172.88M	N/A	0.00%	N/A	N/A	N/A	N/A
WGRX	WELLGISTICS HEALTH INC	$217.65M	N/A	0.00%	N/A	N/A	N/A	N/A
PETS	PETMED EXPRESS INC	$84.48M	N/A	0.00%	$0.3000	N/A	N/A	0
WBA	WALGREENS BOOTS ALLIANCE INC	$9.61B	6.74%	-9.80%	$0.2500	$0.75	89%	1
SSY	SUNLINK HEALTH SYSTEMS INC	$7.18M	N/A	0.00%	N/A	N/A	N/A	N/A
RDGT	RIDGETECH INC	$6.25M	N/A	0.00%	N/A	N/A	N/A	N/A
SCNX	SCIENTURE HOLDINGS INC	$15.18M	0.00%	302.50%	N/A	$0.00	N/A	N/A

Pharmaceutical Retailer Stocks FAQ

What are the best pharmaceutical retailer stocks to buy right now in Mar 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best drug store stocks to buy right now are:

1. 111 (NASDAQ:YI)

111 (NASDAQ:YI) is the #1 top pharmaceutical retailer stock out of 8 with a Zen Rating of C. Stocks with a rating of C have had an average return of +7.53% per year. Learn more.

The Component Grade breakdown for 111 (NASDAQ:YI) is: Value: C, Growth: B, Momentum: C, Sentiment: C, Safety: C, Financials: C, and AI: D.

111 (NASDAQ:YI) has a Due Diligence Score of 24, which is -1 points lower than the pharmaceutical retailer industry average of 25.

YI passed 8 out of 33 due diligence checks and has weak fundamentals. 111 has seen its stock lose -7.52% over the past year, overperforming other pharmaceutical retailer stocks by 33 percentage points.

2. High Tide (NASDAQ:HITI)

High Tide (NASDAQ:HITI) is the #2 top pharmaceutical retailer stock out of 8 with a Zen Rating of C. Stocks with a rating of C have had an average return of +7.53% per year. Learn more.

The Component Grade breakdown for High Tide (NASDAQ:HITI) is: Value: C, Growth: C, Momentum: C, Sentiment: C, Safety: D, Financials: C, and AI: D.

High Tide (NASDAQ:HITI) has a Due Diligence Score of 33, which is 8 points higher than the pharmaceutical retailer industry average of 25.

HITI passed 11 out of 33 due diligence checks and has average fundamentals. High Tide has seen its stock return 13.83% over the past year, overperforming other pharmaceutical retailer stocks by 54 percentage points.

3. Wellgistics Health (NASDAQ:WGRX)

Wellgistics Health (NASDAQ:WGRX) is the #3 top pharmaceutical retailer stock out of 8 with a Zen Rating of C. Stocks with a rating of C have had an average return of +7.53% per year. Learn more.

The Component Grade breakdown for Wellgistics Health (NASDAQ:WGRX) is: Value: C, Growth: C, Momentum: C, Sentiment: C, Safety: D, Financials: D, and AI: C.

Wellgistics Health (NASDAQ:WGRX) has a Due Diligence Score of 4, which is -21 points lower than the pharmaceutical retailer industry average of 25.

WGRX passed 1 out of 33 due diligence checks and has weak fundamentals.

What are the pharmaceutical retailer stocks with highest dividends?

Out of 1 pharmaceutical retailer stocks that have issued dividends in the past year, the 1 pharmaceutical retailer stocks with the highest dividend yields are:

1. Walgreens Boots Alliance (NASDAQ:WBA)

Walgreens Boots Alliance (NASDAQ:WBA) has an annual dividend yield of 6.74%, which is 3 percentage points higher than the pharmaceutical retailer industry average of 3.37%. Walgreens Boots Alliance's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Walgreens Boots Alliance's dividend has not shown consistent growth over the last 10 years.

Walgreens Boots Alliance's dividend payout ratio of -9.8% indicates that its high dividend yield might not be sustainable for the long-term.

Why are pharmaceutical retailer stocks down?

Pharmaceutical retailer stocks were down -0.63% in the last day, and up 2.18% over the last week.

We couldn't find a catalyst for why pharmaceutical retailer stocks are down.

What are the most undervalued pharmaceutical retailer stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued pharmaceutical retailer stocks right now are:

1. High Tide (NASDAQ:HITI)

High Tide (NASDAQ:HITI) is the most undervalued pharmaceutical retailer stock based on its Valuation Rating of C. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

High Tide has a valuation score of 14, which is -2 points higher than the pharmaceutical retailer industry average of 16. It passed 1 out of 7 valuation due diligence checks.

High Tide's stock has gained 13.83% in the past year. It has overperformed other stocks in the pharmaceutical retailer industry by 54 percentage points.

2. 111 (NASDAQ:YI)

111 (NASDAQ:YI) is the second most undervalued pharmaceutical retailer stock based on its Valuation Rating of C. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

111 has a valuation score of 0, which is -16 points higher than the pharmaceutical retailer industry average of 16. It passed 0 out of 7 valuation due diligence checks.

111's stock has dropped -7.52% in the past year. It has overperformed other stocks in the pharmaceutical retailer industry by 33 percentage points.

3. Petmed Express (NASDAQ:PETS)

Petmed Express (NASDAQ:PETS) is the third most undervalued pharmaceutical retailer stock based on its Valuation Rating of C. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Petmed Express has a valuation score of 14, which is -2 points higher than the pharmaceutical retailer industry average of 16. It passed 1 out of 7 valuation due diligence checks.

Petmed Express's stock has dropped -14.08% in the past year. It has overperformed other stocks in the pharmaceutical retailer industry by 26 percentage points.

Are pharmaceutical retailer stocks a good buy now?

100% of pharmaceutical retailer stocks rated by analysts are a sell right now. On average, analysts expect pharmaceutical retailer stocks to fall by -8.72% over the next year.

0% of pharmaceutical retailer stocks have a Zen Rating of A (Strong Buy), 0% of pharmaceutical retailer stocks are rated B (Buy), 100% are rated C (Hold), 0% are rated D (Sell), and 0% are rated F (Strong Sell).

What is the average p/e ratio of the pharmaceutical retailers industry?

The average P/E ratio of the pharmaceutical retailers industry is 1.26x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.